ANDA 74194, held by Perrigo. Loperamide Hydrochloride.
As of Nov 15, 2026, ANDA 74194 (Loperamide Hydrochloride), held by Perrigo, was first approved by FDA on Oct 30, 1992, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 30, 1992 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Loperamide Hydrochloride2MG ยท tablet;oral | Loperamide Hydrochloride | Discontinued |
| Nov 20, 2001 | Supplement 8Labeling | Approved | None posted |
| Jan 24, 1997 | Supplement 5Labeling | Approved | None posted |
| Jan 24, 1997 | Supplement 6Labeling | Approved | None posted |
| Jun 5, 1995 | Supplement 4Labeling | Approved | None posted |
| Mar 1, 1995 | Supplement 2Manufacturing | Approved | None posted |
| Jul 1, 1994 | Supplement 1Labeling | Approved | None posted |
| Oct 30, 1992 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters